Who is sponsoring NCT07126873?

NCT07126873 is sponsored by EndoCell Therapeutics, Inc..

What drugs are being tested in NCT07126873?

Interventions in NCT07126873: Allogeneic Human E-islet (E-islet 01).

What condition does NCT07126873 study?

NCT07126873 studies Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia.

Is NCT07126873 still recruiting?

NCT07126873 is currently recruiting now. Last updated 22 August 2025.

Last reviewed 2025-08-22 · How we verify

NCT07126873

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

Recruiting now Phase 1, PHASE2 Last updated 22 August 2025

What this trial tests

Phase 1, PHASE2 trial testing Allogeneic Human E-islet (E-islet 01) in Diabetes Mellitus, Type 1 in 21 participants. Currently enrolling.

Timeline

11 August 2025

Primary endpoint
31 December 2027

31 December 2029

Quick facts

Lead sponsor	EndoCell Therapeutics, Inc.
Phase	Phase 1, PHASE2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	11 August 2025
Primary completion	31 December 2027
Estimated completion	31 December 2029
Sites	1 location across China

Drugs / interventions tested

Allogeneic Human E-islet (E-islet 01) — full drug profile →

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →
Impaired Hypoglycemic Awareness — all drugs for Impaired Hypoglycemic Awareness →
Severe Hypoglycemia — all drugs for Severe Hypoglycemia →

Sponsor

EndoCell Therapeutics, Inc. — full company profile →

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus, Type 1 or Impaired Hypoglycemic Awareness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07126873 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by EndoCell Therapeutics, Inc.
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07126873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing